Black Diamond Therapeutics
BDTX
BDTX
103 hedge funds and large institutions have $82M invested in Black Diamond Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $92M → $82M (-$10M)
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
Holders
103
Holding in Top 10
–
Calls
$229K
Puts
$221K
Top Buyers
| 1 | +$1.71M | |
| 2 | +$1.65M | |
| 3 | +$1.31M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.21M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$1.17M |
Top Sellers
| 1 | -$2.54M | |
| 2 | -$2.11M | |
| 3 | -$2.06M | |
| 4 |
D.E. Shaw & Co
New York
|
-$694K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$656K |
